In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the ...

West Pharmaceutical Services stock was soaring Thursday after the maker of injectable medicines reported better-than-expected ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results this Thursday morning ...

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and ...

The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

West Pharmaceutical Services forecast full-year results below analysts' estimates on Thursday after the company missed fourth-quarter revenue expectations, hurt by weak demand for its medical ...

This was the stock's second consecutive day of losses.

West Pharmaceutical Services’ operating margin of 26% over the last twelve-month period is better than 18% for Catalent. This compares with 17% and 6% figures seen in 2019, before the pandemic ...

The stock price of West Pharmaceutical Services, best known for injectable pharmaceutical packaging and delivery systems, has rallied around 78% over recent weeks (vs. about a 40% gain in the S&P ...